Table 2.

Endpoint values for secondary outcome measures. Sleep quality is based on an 11-point numerical rating scale, with higher scores indicating better sleep quality. Values are least squares mean (standard error) unless otherwise specified.

VariablesPregabalin, n = 181Placebo, n = 177Difference95% CIp
HADS scores
  HADS-A6.01 (0.28)6.96 (0.28)−0.95−1.40 – −0.50< 0.0001
  HADS-D6.17 (0.31)7.05 (0.31)−0.88−1.37 – − 0.390.0005
FIQ scores
  Total43.78 (1.42)50.38 (1.43)−6.60−9.33 – −3.87< 0.0001
  Subscales
    Physical impairment3.35 (0.17)3.77 (0.17)−0.42−0.74 – −0.110.0078
    Feel good4.69 (0.23)5.53 (0.23)−0.85−1.36 – −0.330.0014
    Work missed2.02 (0.21)2.62 (0.21)−0.59−1.01 – −0.180.0050
    Do work4.56 (0.20)5.31 (0.20)−0.75−1.14 – −0.360.0002
    Pain4.91 (0.17)5.54 (0.17)−0.64−1.00 – −0.280.0006
    Fatigue6.32 (0.19)6.76 (0.19)−0.44−0.85 – −0.040.0315
    Rested5.64 (0.19)6.41 (0.19)−0.76−1.17 – −0.350.0003
    Stiffness5.24 (0.19)5.95 (0.19)−0.71−1.11 – −0.310.0007
    Anxiety3.80 (0.20)4.35 (0.21)−0.55−0.93 – −0.170.0048
    Depression3.20 (0.20)4.13 (0.20)−0.92−1.32 – −0.53< 0.0001
SSQ scores
  Sleep quality6.15 (0.14)5.57 (0.14)0.570.31 – 0.84< 0.0001
  sWASO33.38 (2.73)41.18 (2.76)−7.81−12.66 – −2.960.0018
  LSO33.54 (2.68)39.33 (2.71)−5.80−10.29 – −1.310.0117
  sTST422.98 (5.42)414.63 (5.48)8.35−0.04–16.740.0511
  sNAASO0.48 (0.07)0.61 (0.07)−0.13−0.29–0.030.1139
PSGA score5.83 (0.17)5.27 (0.17)0.550.14–0.970.0085
EQ-5D score0.58 (0.02)0.56 (0.02)0.02−0.02–0.060.3854
  • HADS: Hospital Anxiety and Depression Scale; HADS-A: HADS-Anxiety; HADS-D: HADS-Depression; FIQ: Fibromyalgia Impact Questionnaire; SSQ: subjective sleep questionnaire; sWASO: subjective wake after sleep onset; LSO: latency to sleep onset; sTST: subjective total sleep time; sNAASO: subjective number of awakenings after sleep onset; PSGA: Patient Static Global Assessment.